[1]
M. Ruggeri, A. Signorini, S. Caravaggio, and G. Righi, “A cost-effectiveness analysis of Navina Smart on adult patients affected by neurogenic bowel dysfunction”, Grhta, vol. 11, no. 1, pp. 214–222, Nov. 2024.